ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Vitamin D Deficiency and Autoimmune Diseases

Bibliography link: Vitebskaya A. V., Tikhaya M. I. Vitamin D Deficiency and Autoimmune Diseases. Doctor.Ru. 2017; 4(133): 45–48.
15 May 00:00

Objective of the Review: To describe the role of vitamin D in the development of autoimmune diseases and its effects on the severity of these conditions.

Key Points: The main function of vitamin D is to regulate calcium and phosphorus metabolism. In 2016 the Global Consensus Recommendations on Prevention and Management of Nutritional Rickets were published, which included diagnostic criteria, based on 25OHD concentrations, for vitamin D deficiency and insufficiency, as well as treatment recommendations.

The discovery of vitamin D’s effects on immune reactions suggested that it might play a role in the pathogenesis of autoimmune diseases. Current studies focus on the role of vitamin D in the development and progression of type 1 diabetes mellitus, multiple sclerosis, asthma, rheumatoid arthritis, and systemic lupus erythematosus.

Conclusion: Studies have shown a relationship between vitamin D levels and the severity of autoimmune disorders, but the effects of vitamin D supplementation on the course of these conditions have not been fully evaluated.

A. V. Vitebskaya — I. M. Sechenov First Moscow State Medical University, Russian Ministry of Health. E-mail: dr.vitebskaya@gmail.com

M. I. Tikhaya — City Pediatric Outpatient Clinic No. 104, Moscow City Department of Health. E-mail: plaksinamargarita@gmail.com

Доктор.ру
15 May 00:00
LITERATURE
  1. Орлова Е. М., Созаева Л. С, Маказан Н. В. Гипопаратиреоз у детей: клинические варианты, современная диагностика и лечение (лекция для врачей) // Доктор.Ру. 2014. № 11 (99). С. 27–30. [Orlova E. M., Sozaeva L. S, Makazan N. V. Gipoparatireoz u detei: klinicheskie varianty, sovremennaya diagnostika i lechenie (lektsiya dlya vrachei). Doktor.Ru. 2014; 11(99): 27–30. (in Russian)]
  2. Adams J. S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity // Nat. Clin. Pract. Endocrinol. Metab. 2008. Vol. 4. N 2. P. 80–90.
  3. Aljabri K. S., Bokhari S. A., Khan M. J. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency // Ann. Saudi Med. 2010. Vol. 30. N 6. P. 454–458.
  4. Brehm J. M., Schuemann B., Fuhlbrigge A. L., Hollis B. W. et al.; Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study // J. Allergy Clin. Immunol. 2010. Vol. 126. N 1. P. 52–58.
  5. Chen S., Sims G. P., Chen X. X., Gu Y. Y. et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation // J. Immunol. 2007. Vol. 179. N 3. P. 1634–1647.
  6. Chung M., Balk E. M., Brendel M., Ip S. et al. Vitamin D and calcium: a systematic review of health outcomes // Evid. Rep. Technol. Assess. (Full Rep.). 2009. Vol. 183. P. 1–420.
  7. Cortese M., Riise T., Bjørnevik K., Holmøy T. et al. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study // Mult. Scler. 2015. Vol. 21. N 14. P. 1856–1864.
  8. DeLuca H. F. Overview of general physiologic features and functions of vitamin D // Am. J. Clin. Nutr. 2004. Vol. 80. N 6 (Suppl.). P. S1689–1696.
  9. Derakhshandi H., Etemadifar M., Feizi A., Abtahi S. H. et al. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial // Acta Neurol. Belg. 2013. Vol. 113. N 3. P. 257–263.
  10. Di Franco M., Barchetta I., Iannuccelli C., Gerardi M. C. et al. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study // BMC Musculoskelet. Disord. 2015. Vol. 16: 53.
  11. Dietary reference intakes for calcium and vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; A. C. Ross, C. L. Taylor, A. L. Yaktine, H. B. Del Valle, eds. Washington (DC): National Academies Press (US), 2011.
  12. Etemadifar M., Janghorbani M. Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial // Iran J. Neurol. 2015. Vol. 14. N 2. P. 67–73.
  13. Feng R., Li Y., Li G., Li Z. et al. Lower serum 25(OH)D concentrations in type 1 diabetes: A meta-analysis // Diabetes Res. Clin. Pract. 2015. Vol. 108. N 3. P. e71–75.
  14. Ganesh A., Apel S., Metz L., Patten S. The case for vitamin D supplementation in multiple sclerosis // Mult. Scler. Relat. Disord. 2013. Vol. 2. N 4. P. 281–306.
  15. Guo Y. Y., Wang N. Z., Zhao S., Hou L. X. et al. Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis // Chin. Med. J. 2013. Vol. 126. N 5. P. 850–854.
  16. Holick M. F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease // Am. J. Clin. Nutr. 2004. Vol. 80. N 6 (Suppl.). P. S1678–1688.
  17. Hong Q., Xu J., Xu S., Lian L. et al. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis // Rheumatology (Oxford). 2014. Vol. 53. N 11. P. 1994–2001.
  18. Huynh T., Greer R. M., Nyunt O., Bowling F. et al. The association between ketoacidosis and 25(OH)-vitamin D levels at presentation in children with type 1 diabetes mellitus // Pediatr. Diabetes. 2009. Vol. 10. P. 38–43.
  19. James E., Dobson R., Kuhle J., Baker D. et al. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis // Mult. Scler. 2013. Vol. 19. N 12. P. 1571–1579.
  20. Jelinek G. A., Marck C. H., Weiland T. J., Pereira N. et al. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis // BMC Neurol. 2015. Vol. 15: 132.
  21. Mok C. C., Birmingham D. J., Ho L. Y., Hebert L. A. et al. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q // Lupus. 2012. Vol. 21. N 1. P. 36–42.
  22. Munns C. F., Shaw N., Kiely M., Specker B. L. et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets // J. Clin. Endocrinol. Metab. 2016. Vol. 101. N 2. P. 394–415.
  23. Paul G., Brehm J. M., Alcorn J. F., Holguín F. et al. Vitamin D and asthma // Am. J. Respir. Crit. Care Med. 2012. Vol. 185. N 2. P. 124–132.
  24. Pozuelo-Moyano B., Benito-León J., Mitchell A. J., Hernández-Gallego J. A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis // Neuroepidemiology. 2013. Vol. 40. N 3. P. 147–153.
  25. Raab J., Giannopoulou E. Z., Schneider S., Warncke K. et al. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression // Diabetologia. 2014. Vol. 57. N 5. P. 902–908.
  26. Riverin B. D., Maguire J. L., Li P. Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis // PLoS One. 2015. Vol. 10. N 8: e0136841.
  27. Ruiz-Irastorza G., Gordo S., Olivares N., Egurbide M. V. et al. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage // Arthritis Care Res. (Hoboken). 2010. Vol. 62. N 8. P. 1160–1165.
  28. Terrier B., Derian N., Schoindre Y., Chaara W. et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation // Arthritis Res. Ther. 2012. Vol. 14. N 5: R221.
  29. Veldman C. M., Cantorna M. T., DeLuca H. F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system // Arch. Biochem. Biophys. 2000. Vol. 374. N 2. P. 334–338.
  30. Vogiatzi M. G., Jacobson-Dickman E., DeBoer M. D.; Drugs, and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature // J. Clin. Endocrinol. Metab. 2014. Vol. 99. N 4. P. 1132–1141.
  31. Yap K. S., Northcott M., Hoi A. B., Morand E. F. et al. Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort // Lupus Sci. Med. 2015. Vol. 2. N 1: e000064.
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)

News